These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7094197)

  • 1. Pharmacokinetics and metabolism of beta-2'-deoxythioguanosine and 6-thioguanine in man.
    Lu K; Benvenuto JA; Bodey GP; Gottlieb JA; Rosenblum MG; Loo TL
    Cancer Chemother Pharmacol; 1982; 8(1):119-23. PubMed ID: 7094197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition and metabolism of thiopurines III. beta-2'-Deoxythioguanosine and 6-thioguanine in the dog.
    Loo TL; Lu K; Benvenuto JA; Rosenblum MG
    Cancer Chemother Pharmacol; 1981; 6(2):131-6. PubMed ID: 7307231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology and toxicology of alpha-2'-deoxythioguanosine in cancer patients.
    LePage GA; Khaliq A
    Cancer Treat Rep; 1979 Jan; 63(1):53-7. PubMed ID: 421233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo effects in mice produced by a 3'-branched homologue of alpha-2'-deoxythioguanosine.
    LePage GA; Banks PA; Noujaim MJ; Buzzell GR
    Cancer Chemother Pharmacol; 1980; 5(2):127-31. PubMed ID: 6894108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved antitumor effects in 3'-branched homologues of 2'-deoxythioguanosine. Synthesis and evaluation of thioguanine nucleosides of 2,3-dideoxy-3-(hydroxymethyl)-D-erythro-pentofuranose.
    Acton EM; Goerner RN; Uh HS; Ryan KJ; Henry DW; Cass CE; LePage GA
    J Med Chem; 1979 May; 22(5):518-25. PubMed ID: 582321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinational chemotherapy of L1210 and L1210/ARA-C leukemia with 5-AZA-2'-deoxycytidine and beta-2'-deoxythioguanosine.
    Momparler RL; Momparler LF; Samson J
    Int J Cancer; 1982 Sep; 30(3):361-64. PubMed ID: 6182115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2' -DEOXYTHIOGUANOSINE AND RELATED NUCLEOSIDES.
    IWAMOTO RH; ACTON EM; GOODMAN L
    J Med Chem; 1963 Nov; 6():684-8. PubMed ID: 14184926
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2'-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl)-1(2-chlorethyl)-1-nitrosourea: a Phase II-III study of the Eastern Cooperative Oncology Group (EST 4273).
    Douglass HO; Lavin PT; Woll J; Conroy JF; Carbone P
    Cancer; 1978 Dec; 42(6):2538-45. PubMed ID: 365312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting 6-thioguanine to the kidney with S-(guanin-6-yl)-L-cysteine.
    Elfarra AA; Duescher RJ; Hwang IY; Sicuri AR; Nelson JA
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1298-304. PubMed ID: 7562502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human RNase H-mediated RNA cleavage from DNA-RNA duplexes is inhibited by 6-deoxythioguanosine incorporation into DNA.
    Krynetskaia NF; Krynetski EY; Evans WE
    Mol Pharmacol; 1999 Oct; 56(4):841-8. PubMed ID: 10496969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transport and metabolism of 6-thioguanine and 6-mercaptopurine in mouse small intestine.
    Bronk JR; Lister N; Shaw MI
    Clin Sci (Lond); 1988 Jun; 74(6):629-38. PubMed ID: 3396300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of thiopurine methyltransferase expression on sensitivity to thiopurine drugs.
    Coulthard SA; Hogarth LA; Little M; Matheson EC; Redfern CP; Minto L; Hall AG
    Mol Pharmacol; 2002 Jul; 62(1):102-9. PubMed ID: 12065760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells.
    Dervieux T; Blanco JG; Krynetski EY; Vanin EF; Roussel MF; Relling MV
    Cancer Res; 2001 Aug; 61(15):5810-6. PubMed ID: 11479220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I evaluation of beta-2'-deoxythioguanosine in pediatric patients with leukemia.
    Higgins GR; Jamin DC; Shore NA; Momparler R; Hartman G; Siegel SE
    Cancer Treat Rep; 1985 Jun; 69(6):699-701. PubMed ID: 3860294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct tissue distribution of metabolites of the novel glutathione-activated thiopurine prodrugs cis-6-(2-acetylvinylthio)purine and trans-6-(2-acetylvinylthio)guanine and 6-thioguanine in the mouse.
    Gunnarsdottir S; Elfarra AA
    Drug Metab Dispos; 2003 Jun; 31(6):718-26. PubMed ID: 12756203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and tissue disposition of the biological response modifier BAY i 7433 (copovithane) in patients with cancer.
    Rosenblum MG; Hortobagyi GN
    Cancer Chemother Pharmacol; 1986; 18(3):247-51. PubMed ID: 3802380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of the 6-thiopurines.
    Grindey GB
    Cancer Treat Rev; 1979 Jun; 6 Suppl():19-25. PubMed ID: 387229
    [No Abstract]   [Full Text] [Related]  

  • 18. Formation of 6-thioguanine and 6-mercaptopurine from their 9-alkyl derivatives in mice.
    Nelson JA; Vidale E
    Cancer Res; 1986 Jan; 46(1):137-40. PubMed ID: 3940185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/pharmacokinetic study of thioguanine administered as a 48-hour continuous intraperitoneal infusion.
    Zimm S; Cleary SM; Horton CN; Howell SB
    J Clin Oncol; 1988 Apr; 6(4):696-700. PubMed ID: 3357007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thioguanine administered as a continuous intravenous infusion to pediatric patients is metabolized to the novel metabolite 8-hydroxy-thioguanine.
    Kitchen BJ; Moser A; Lowe E; Balis FM; Widemann B; Anderson L; Strong J; Blaney SM; Berg SL; O'Brien M; Adamson PC
    J Pharmacol Exp Ther; 1999 Nov; 291(2):870-4. PubMed ID: 10525111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.